Results 161 to 170 of about 96,533 (188)

Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes

Nature Medicine, 2021
Róbert Wagner, Martin Heni, Adam G Tabak   +2 more
exaly  

Assessment of anxiety in open field and elevated plus maze using infrared thermography

Physiology and Behavior, 2016
Benjamin Lecorps, Heiko G. Rödel, C. Féron   +2 more
semanticscholar   +1 more source

The use of a plus-maze to measure anxiety in the mouse

Psychopharmacology, 2004
R. Lister
semanticscholar   +1 more source

Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors

Nature Medicine, 2020
Kurt A Schalper, Ming Zhou, Alice M Walsh   +2 more
exaly  

A review of the validity and variability of the Elevated Plus-Maze as an animal model of anxiety

Pharmacology, Biochemistry and Behavior, 1996
S. Hogg
semanticscholar   +1 more source

The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012

Ca-A Cancer Journal for Clinicians, 2017
Ahmedin Jemal, Anil K Chaturvedi, Frank Bray   +2 more
exaly  

Pharmacological Effects of Origanum Vulgare L. in the Elevated Plus-Maze and Open Field Tests in the Rat

, 2015
T. Mombeini, S. Mazloumi, J. Shams
semanticscholar   +1 more source

Temporal analysis of free exploration of an elevated plus-maze in mice.

Journal of Experimental Psychology: Animal Learning and Cognition, 2014
A. Arabo, C. Potier, Gaëlle Ollivier, T. Lorivel, V. Roy   +4 more
semanticscholar   +1 more source

Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

Nature Reviews Clinical Oncology, 2020
Lorenzo Galluzzi, Juliette Humeau, Aitziber Buqué   +2 more
exaly  

Anxiety, defence and the elevated plus-maze

Neuroscience and Biobehavioral Reviews, 1997
R. Rodgers, A. Dalvi
semanticscholar   +1 more source